pf-07901801
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 7, 2022 (NCT05626322)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4802185 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05896163 | Phase 2 | Aug 30, 2023 | Pfizer, Roche |
| NCT05896774 | Phase 1 | Jun 28, 2023 | Pfizer |
| NCT05675449 | Phase 1 | Dec 14, 2022 | Pfizer |
| NCT05626322 | Phase 2 | Dec 7, 2022 | Incyte, MorphoSys, Pfizer |
Showing 4 of 4 trials
Page 1 / 1